Clinical Trial Update: Autologous TLPO Vaccine Basket [Phase 2]

View source ↗

Summary

Phase 2 trial of an autologous TLPO vaccine basket sponsored by Elios Therapeutics has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumor

Drugs mentioned

• Autologous TLPO Vaccine Basket

Snippet

Sponsor: Elios Therapeutics, LLC | Conditions: Tumor, Solid, Tumor Metastasis | Phase 2 | Status: TERMINATED